Literature DB >> 11387920

Chickenpox vaccination, not chickenpox, should be routine for Canadian children.

B J Law1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11387920      PMCID： PMC81074     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  16 in total

1.  The effectiveness of the varicella vaccine in clinical practice.

Authors:  M Vázquez; P S LaRussa; A A Gershon; S P Steinberg; K Freudigman; E D Shapiro
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication.

Authors:  B Law; N MacDonald; S Halperin; D Scheifele; P Déry; T Jadavji; M H Lebel; E Mills; R Morris; W Vaudry; R Gold; V Marchessault; P Duclos
Journal:  Pediatr Infect Dis J       Date:  2000-11       Impact factor: 2.129

3.  Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.

Authors:  B J Kuter; R E Weibel; H A Guess; H Matthews; D H Morton; B J Neff; P J Provost; B A Watson; S E Starr; S A Plotkin
Journal:  Vaccine       Date:  1991-09       Impact factor: 3.641

4.  Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.

Authors:  C J White; B J Kuter; C S Hildebrand; K L Isganitis; H Matthews; W J Miller; P J Provost; R W Ellis; R J Gerety; G B Calandra
Journal:  Pediatrics       Date:  1991-05       Impact factor: 7.124

5.  Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine.

Authors:  L Zerboni; S Nader; K Aoki; A M Arvin
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

6.  Cost of chickenpox in Canada: part I. Cost of uncomplicated cases.

Authors:  B Law; C Fitzsimon; L Ford-Jones; N MacDonald; P Déry; W Vaudry; E Mills; S Halperin; A Michaliszyn; M Rivière
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

7.  A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.

Authors:  K Ueda; K Tokugawa; F Nakashima; M Takahashi
Journal:  Biken J       Date:  1984-09

8.  Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.

Authors:  Y Asano; S Suga; T Yoshikawa; I Kobayashi; T Yazaki; M Shibata; K Tsuzuki; S Ito
Journal:  Pediatrics       Date:  1994-10       Impact factor: 7.124

9.  Postlicensure safety surveillance for varicella vaccine.

Authors:  R P Wise; M E Salive; M M Braun; G T Mootrey; J F Seward; L G Rider; P R Krause
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

10.  Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.

Authors:  H H Bernstein; E P Rothstein; B M Watson; K S Reisinger; M M Blatter; C O Wellman; S A Chartrand; I Cho; A Ngai; C J White
Journal:  Pediatrics       Date:  1993-12       Impact factor: 7.124
View more
  3 in total

1.  A patchwork policy: vaccination in Canada.

Authors: 
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

2.  Varicella vaccine update: need for a booster?

Authors:  John Hoey
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

3.  Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†.

Authors:  Alexia Campbell; Shainoor Ismail; Ben Tan
Journal:  Can Commun Dis Rep       Date:  2010-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.